WallStreetZen

NYSE: LLY
ELI LILLY & Co Stock Forecast, Predictions & Price Target

Analyst price target for LLY

Based on 11 analysts offering 12 month price targets for ELI LILLY & Co.
Min Forecast
$144.00-30.14%
Avg Forecast
$187.91-8.84%
Max Forecast
$225.00+9.15%

Should I buy or sell LLY stock?

Strong Buy
Strong Buy
9 analysts 75%
Buy
0 analysts 0%
Hold
3 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is LLY forecast to generate an efficient return?
Company
235.8%
Industry
75.54%
Market
61.82%
LLY's Return on Equity is forecast to be high in 4 years (235.8%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is LLY forecast to generate an efficient return on assets?
Company
25.9%
Industry
16.98%
Market
19.68%
LLY is forecast to generate higher Return on Assets (25.9%) than the US Drug Manufacturers - General industry average (16.98%)
Forecast

LLY earnings per share forecast

What is LLY's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$8.08+31.45%
Avg 2 year Forecast
$8.71+41.63%
Avg 3 year Forecast
$10.34+68.13%
LLY's earnings are forecast to grow at a rate of 17.08% per year, which is not exceptional
Forecast

LLY revenue forecast

What is LLY's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$27.5B+18.27%
Avg 2 year Forecast
$28.1B+21.1%
Avg 3 year Forecast
$30.1B+29.78%
LLY's revenue is forecast to grow at a rate of 8.46% per year, which is not exceptional
Forecast

LLY earnings growth forecast

How is LLY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
17.08%
Industry
25.04%
Market
20.34%
LLY's earnings are forecast to grow slower (17.08% per year) than the US Drug Manufacturers - General industry average (25.04%)
Forecast
LLY's earnings are forecast to grow slower (17.08% per year) than the US market average (20.34%)
Forecast
LLY's earnings are forecast to grow faster (17.08% per year) than the risk-free savings rate (1.1%)
Forecast

LLY revenue growth forecast

How is LLY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
8.46%
Industry
6.45%
Market
14.82%
LLY's revenues are forecast to grow faster (8.46% per year) than the US Drug Manufacturers - General industry average (6.45%)
Forecast
LLY's revenues are forecast to grow slower (8.46% per year) than the US market average (14.82%)
Forecast

ELI LILLY & Stock Forecast FAQ

Is ELI LILLY & Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: LLY) stock is to Strong Buy LLY stock.

Out of 12 analysts, 9 (75%) are recommending LLY as a Strong Buy, 0 (0%) are recommending LLY as a Buy, 3 (25%) are recommending LLY as a Hold, 0 (0%) are recommending LLY as a Sell, and 0 (0%) are recommending LLY as a Strong Sell.

What is LLY's Price Target?

According to 11 Wall Street analysts that have issued a 1 year LLY price target, the average LLY price target is $187.91, with the highest LLY stock price forecast at $225.00 and the lowest LLY stock price forecast at $144.00.

On average, Wall Street analysts predict that ELI LILLY &'s share price could fall to $187.91 by Jan 22, 2022. The average ELI LILLY & stock price prediction forecasts a potential downside of 8.84% from the current LLY share price of $206.14.

What is LLY's earnings growth forecast for 2021-2023?

(NYSE: LLY) ELI LILLY &'s forecast annual earnings growth rate of 17.08% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 25.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.34%.

ELI LILLY &'s earnings in 2020 is $5,572,600,000.On average, 7 Wall Street analysts forecast LLY's earnings for 2021 to be $7,732,393,428, with the lowest LLY earnings forecast at $7,412,645,383, and the highest LLY earnings forecast at $7,986,527,606. On average, 4 Wall Street analysts forecast LLY's earnings for 2022 to be $8,330,856,940, with the lowest LLY earnings forecast at $7,795,233,532, and the highest LLY earnings forecast at $8,675,186,274.

In 2023, LLY is forecast to generate $9,889,903,646 in earnings, with the lowest earnings forecast at $9,889,903,646 and the highest earnings forecast at $9,889,903,646.

What is LLY's revenue growth forecast for 2021-2023?

(NYSE: LLY) ELI LILLY &'s forecast annual revenue growth rate of 8.46% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.82%.

ELI LILLY &'s revenue in 2020 is $23,213,800,000.On average, 3 Wall Street analysts forecast LLY's revenue for 2021 to be $26,259,230,272,822, with the lowest LLY revenue forecast at $26,069,393,859,269, and the highest LLY revenue forecast at $26,409,103,441,292. On average, 3 Wall Street analysts forecast LLY's revenue for 2022 to be $26,887,239,154,373, with the lowest LLY revenue forecast at $26,792,648,060,464, and the highest LLY revenue forecast at $27,036,595,828,843.

In 2023, LLY is forecast to generate $28,816,539,367,616 in revenue, with the lowest revenue forecast at $28,816,539,367,616 and the highest revenue forecast at $28,816,539,367,616.

What is LLY's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: LLY) ELI LILLY &'s current Earnings Per Share (EPS) is $6.15. On average, analysts forecast that LLY's EPS will be $8.08 for 2021, with the lowest EPS forecast at $7.75, and the highest EPS forecast at $8.35. On average, analysts forecast that LLY's EPS will be $8.71 for 2022, with the lowest EPS forecast at $8.15, and the highest EPS forecast at $9.07. In 2023, LLY's EPS is forecast to hit $10.34 (min: $10.34, max: $10.34).

What is LLY's forecast return on equity (ROE) for 2021-2024?

(NYSE: LLY) forecast ROE is 235.8%, which is considered strong.

What is LLY's forecast return on assets (ROA) for 2021-2024?

(NYSE: LLY) forecast ROA is 25.9%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.98%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics